Heron Therapeutics(HRTX) - 2022 Q4 - Earnings Call Presentation

Heron Update Q4 2022 Earnings Call Forward-Looking Statements This presentation contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. We caution investors that forward-looking statements are based on management's expectations and assumptions as of the date of this presentation, and involve substantial risks and uncertainties that could cause our clinical development programs, future results, performance or achievements to differ significantly from those ex ...